The global market for Opthalmic Pharmaceutical Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opthalmic Pharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opthalmic Pharmaceutical Drugs.

The Opthalmic Pharmaceutical Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opthalmic Pharmaceutical Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opthalmic Pharmaceutical Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Opthalmic Pharmaceutical Drugs Market Report

Report Metric	Details
Report Name	Opthalmic Pharmaceutical Drugs Market
CAGR	5%
Segment by Type	Anti-glaucoma Anti-infection Anti-inflammatory Anti-allergy
Segment by Application	Hospital Pharmacies Drug Stores Online Pharmacies Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma, Topcon Corporation, Ziemer Ophthalmic Systems
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opthalmic Pharmaceutical Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opthalmic Pharmaceutical Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Opthalmic Pharmaceutical Drugs Market report?

Ans: The main players in the Opthalmic Pharmaceutical Drugs Market are Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma, Topcon Corporation, Ziemer Ophthalmic Systems

What are the Application segmentation covered in the Opthalmic Pharmaceutical Drugs Market report?

Ans: The Applications covered in the Opthalmic Pharmaceutical Drugs Market report are Hospital Pharmacies, Drug Stores, Online Pharmacies, Others

What are the Type segmentation covered in the Opthalmic Pharmaceutical Drugs Market report?

Ans: The Types covered in the Opthalmic Pharmaceutical Drugs Market report are Anti-glaucoma, Anti-infection, Anti-inflammatory, Anti-allergy

1 Opthalmic Pharmaceutical Drugs Market Overview

1.1 Product Definition

1.2 Opthalmic Pharmaceutical Drugs by Type

1.2.1 Global Opthalmic Pharmaceutical Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Anti-glaucoma

1.2.3 Anti-infection

1.2.4 Anti-inflammatory

1.2.5 Anti-allergy

1.3 Opthalmic Pharmaceutical Drugs by Application

1.3.1 Global Opthalmic Pharmaceutical Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Drug Stores

1.3.4 Online Pharmacies

1.3.5 Others

1.4 Global Opthalmic Pharmaceutical Drugs Market Size Estimates and Forecasts

1.4.1 Global Opthalmic Pharmaceutical Drugs Revenue 2020-2031

1.4.2 Global Opthalmic Pharmaceutical Drugs Sales 2020-2031

1.4.3 Global Opthalmic Pharmaceutical Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Opthalmic Pharmaceutical Drugs Market Competition by Manufacturers

2.1 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Opthalmic Pharmaceutical Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Opthalmic Pharmaceutical Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Product Type & Application

2.7 Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Date of Enter into This Industry

2.8 Global Opthalmic Pharmaceutical Drugs Market Competitive Situation and Trends

2.8.1 Global Opthalmic Pharmaceutical Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Opthalmic Pharmaceutical Drugs Players Market Share by Revenue

2.8.3 Global Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Opthalmic Pharmaceutical Drugs Market Scenario by Region

3.1 Global Opthalmic Pharmaceutical Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Opthalmic Pharmaceutical Drugs Sales by Region: 2020-2031

3.2.1 Global Opthalmic Pharmaceutical Drugs Sales by Region: 2020-2025

3.2.2 Global Opthalmic Pharmaceutical Drugs Sales by Region: 2026-2031

3.3 Global Opthalmic Pharmaceutical Drugs Revenue by Region: 2020-2031

3.3.1 Global Opthalmic Pharmaceutical Drugs Revenue by Region: 2020-2025

3.3.2 Global Opthalmic Pharmaceutical Drugs Revenue by Region: 2026-2031

3.4 North America Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country

3.4.1 North America Opthalmic Pharmaceutical Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Opthalmic Pharmaceutical Drugs Sales by Country (2020-2031)

3.4.3 North America Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country

3.5.1 Europe Opthalmic Pharmaceutical Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Opthalmic Pharmaceutical Drugs Sales by Country (2020-2031)

3.5.3 Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Opthalmic Pharmaceutical Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Opthalmic Pharmaceutical Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country

3.7.1 Latin America Opthalmic Pharmaceutical Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2020-2031)

3.7.3 Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Opthalmic Pharmaceutical Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Opthalmic Pharmaceutical Drugs Sales by Type (2020-2031)

4.1.1 Global Opthalmic Pharmaceutical Drugs Sales by Type (2020-2025)

4.1.2 Global Opthalmic Pharmaceutical Drugs Sales by Type (2026-2031)

4.1.3 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2020-2031)

4.2 Global Opthalmic Pharmaceutical Drugs Revenue by Type (2020-2031)

4.2.1 Global Opthalmic Pharmaceutical Drugs Revenue by Type (2020-2025)

4.2.2 Global Opthalmic Pharmaceutical Drugs Revenue by Type (2026-2031)

4.2.3 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Opthalmic Pharmaceutical Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Opthalmic Pharmaceutical Drugs Sales by Application (2020-2031)

5.1.1 Global Opthalmic Pharmaceutical Drugs Sales by Application (2020-2025)

5.1.2 Global Opthalmic Pharmaceutical Drugs Sales by Application (2026-2031)

5.1.3 Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2020-2031)

5.2 Global Opthalmic Pharmaceutical Drugs Revenue by Application (2020-2031)

5.2.1 Global Opthalmic Pharmaceutical Drugs Revenue by Application (2020-2025)

5.2.2 Global Opthalmic Pharmaceutical Drugs Revenue by Application (2026-2031)

5.2.3 Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Opthalmic Pharmaceutical Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Company Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Johnson & Johnson Opthalmic Pharmaceutical Drugs Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Carl-Zeiss

6.2.1 Carl-Zeiss Company Information

6.2.2 Carl-Zeiss Description and Business Overview

6.2.3 Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Carl-Zeiss Opthalmic Pharmaceutical Drugs Product Portfolio

6.2.5 Carl-Zeiss Recent Developments/Updates

6.3 Ellex Medical Lasers

6.3.1 Ellex Medical Lasers Company Information

6.3.2 Ellex Medical Lasers Description and Business Overview

6.3.3 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product Portfolio

6.3.5 Ellex Medical Lasers Recent Developments/Updates

6.4 Essilor International

6.4.1 Essilor International Company Information

6.4.2 Essilor International Description and Business Overview

6.4.3 Essilor International Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Essilor International Opthalmic Pharmaceutical Drugs Product Portfolio

6.4.5 Essilor International Recent Developments/Updates

6.5 Hoya Corporation

6.5.1 Hoya Corporation Company Information

6.5.2 Hoya Corporation Description and Business Overview

6.5.3 Hoya Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Hoya Corporation Opthalmic Pharmaceutical Drugs Product Portfolio

6.5.5 Hoya Corporation Recent Developments/Updates

6.6 Insight Vision

6.6.1 Insight Vision Company Information

6.6.2 Insight Vision Description and Business Overview

6.6.3 Insight Vision Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Insight Vision Opthalmic Pharmaceutical Drugs Product Portfolio

6.6.5 Insight Vision Recent Developments/Updates

6.7 Nidek

6.7.1 Nidek Company Information

6.7.2 Nidek Description and Business Overview

6.7.3 Nidek Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nidek Opthalmic Pharmaceutical Drugs Product Portfolio

6.7.5 Nidek Recent Developments/Updates

6.8 Novagali Pharma

6.8.1 Novagali Pharma Company Information

6.8.2 Novagali Pharma Description and Business Overview

6.8.3 Novagali Pharma Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novagali Pharma Opthalmic Pharmaceutical Drugs Product Portfolio

6.8.5 Novagali Pharma Recent Developments/Updates

6.9 Topcon Corporation

6.9.1 Topcon Corporation Company Information

6.9.2 Topcon Corporation Description and Business Overview

6.9.3 Topcon Corporation Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Topcon Corporation Opthalmic Pharmaceutical Drugs Product Portfolio

6.9.5 Topcon Corporation Recent Developments/Updates

6.10 Ziemer Ophthalmic Systems

6.10.1 Ziemer Ophthalmic Systems Company Information

6.10.2 Ziemer Ophthalmic Systems Description and Business Overview

6.10.3 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product Portfolio

6.10.5 Ziemer Ophthalmic Systems Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Opthalmic Pharmaceutical Drugs Industry Chain Analysis

7.2 Opthalmic Pharmaceutical Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Opthalmic Pharmaceutical Drugs Production Mode & Process Analysis

7.4 Opthalmic Pharmaceutical Drugs Sales and Marketing

7.4.1 Opthalmic Pharmaceutical Drugs Sales Channels

7.4.2 Opthalmic Pharmaceutical Drugs Distributors

7.5 Opthalmic Pharmaceutical Drugs Customer Analysis

8 Opthalmic Pharmaceutical Drugs Market Dynamics

8.1 Opthalmic Pharmaceutical Drugs Industry Trends

8.2 Opthalmic Pharmaceutical Drugs Market Drivers

8.3 Opthalmic Pharmaceutical Drugs Market Challenges

8.4 Opthalmic Pharmaceutical Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Carl Zeiss

Ellex Medical Lasers

Essilor International

Ziemer Ophthalmic Systems

List of Tables

Table 1. Global Opthalmic Pharmaceutical Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Opthalmic Pharmaceutical Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Opthalmic Pharmaceutical Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Opthalmic Pharmaceutical Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Opthalmic Pharmaceutical Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Opthalmic Pharmaceutical Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Opthalmic Pharmaceutical Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Opthalmic Pharmaceutical Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Opthalmic Pharmaceutical Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opthalmic Pharmaceutical Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Opthalmic Pharmaceutical Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Opthalmic Pharmaceutical Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Opthalmic Pharmaceutical Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Opthalmic Pharmaceutical Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Opthalmic Pharmaceutical Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Opthalmic Pharmaceutical Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Opthalmic Pharmaceutical Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Opthalmic Pharmaceutical Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Opthalmic Pharmaceutical Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Opthalmic Pharmaceutical Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Opthalmic Pharmaceutical Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Opthalmic Pharmaceutical Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Opthalmic Pharmaceutical Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Opthalmic Pharmaceutical Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Opthalmic Pharmaceutical Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Opthalmic Pharmaceutical Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Opthalmic Pharmaceutical Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Opthalmic Pharmaceutical Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Opthalmic Pharmaceutical Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Opthalmic Pharmaceutical Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Opthalmic Pharmaceutical Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Johnson & Johnson Company Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Johnson & Johnson Opthalmic Pharmaceutical Drugs Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Carl-Zeiss Company Information

Table 76. Carl-Zeiss Description and Business Overview

Table 77. Carl-Zeiss Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Carl-Zeiss Opthalmic Pharmaceutical Drugs Product

Table 79. Carl-Zeiss Recent Developments/Updates

Table 80. Ellex Medical Lasers Company Information

Table 81. Ellex Medical Lasers Description and Business Overview

Table 82. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Ellex Medical Lasers Opthalmic Pharmaceutical Drugs Product

Table 84. Ellex Medical Lasers Recent Developments/Updates

Table 85. Essilor International Company Information

Table 86. Essilor International Description and Business Overview

Table 87. Essilor International Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Essilor International Opthalmic Pharmaceutical Drugs Product

Table 89. Essilor International Recent Developments/Updates

Table 90. Hoya Corporation Company Information

Table 91. Hoya Corporation Description and Business Overview

Table 92. Hoya Corporation Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Hoya Corporation Opthalmic Pharmaceutical Drugs Product

Table 94. Hoya Corporation Recent Developments/Updates

Table 95. Insight Vision Company Information

Table 96. Insight Vision Description and Business Overview

Table 97. Insight Vision Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Insight Vision Opthalmic Pharmaceutical Drugs Product

Table 99. Insight Vision Recent Developments/Updates

Table 100. Nidek Company Information

Table 101. Nidek Description and Business Overview

Table 102. Nidek Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Nidek Opthalmic Pharmaceutical Drugs Product

Table 104. Nidek Recent Developments/Updates

Table 105. Novagali Pharma Company Information

Table 106. Novagali Pharma Description and Business Overview

Table 107. Novagali Pharma Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Novagali Pharma Opthalmic Pharmaceutical Drugs Product

Table 109. Novagali Pharma Recent Developments/Updates

Table 110. Topcon Corporation Company Information

Table 111. Topcon Corporation Description and Business Overview

Table 112. Topcon Corporation Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Topcon Corporation Opthalmic Pharmaceutical Drugs Product

Table 114. Topcon Corporation Recent Developments/Updates

Table 115. Ziemer Ophthalmic Systems Company Information

Table 116. Ziemer Ophthalmic Systems Description and Business Overview

Table 117. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Ziemer Ophthalmic Systems Opthalmic Pharmaceutical Drugs Product

Table 119. Ziemer Ophthalmic Systems Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Opthalmic Pharmaceutical Drugs Distributors List

Table 123. Opthalmic Pharmaceutical Drugs Customers List

Table 124. Opthalmic Pharmaceutical Drugs Market Trends

Table 125. Opthalmic Pharmaceutical Drugs Market Drivers

Table 126. Opthalmic Pharmaceutical Drugs Market Challenges

Table 127. Opthalmic Pharmaceutical Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Opthalmic Pharmaceutical Drugs

Figure 2. Global Opthalmic Pharmaceutical Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Opthalmic Pharmaceutical Drugs Market Share by Type: 2024 & 2031

Figure 4. Anti-glaucoma Product Picture

Figure 5. Anti-infection Product Picture

Figure 6. Anti-inflammatory Product Picture

Figure 7. Anti-allergy Product Picture

Figure 8. Global Opthalmic Pharmaceutical Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Opthalmic Pharmaceutical Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital Pharmacies

Figure 11. Drug Stores

Figure 12. Online Pharmacies

Figure 13. Others

Figure 14. Global Opthalmic Pharmaceutical Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Opthalmic Pharmaceutical Drugs Market Size (2020-2031) & (US$ Million)

Figure 16. Global Opthalmic Pharmaceutical Drugs Sales (2020-2031) & (K Units)

Figure 17. Global Opthalmic Pharmaceutical Drugs Average Price (USD/Unit) & (2020-2031)

Figure 18. Opthalmic Pharmaceutical Drugs Report Years Considered

Figure 19. Opthalmic Pharmaceutical Drugs Sales Share by Manufacturers in 2024

Figure 20. Global Opthalmic Pharmaceutical Drugs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Opthalmic Pharmaceutical Drugs Players: Market Share by Revenue in Opthalmic Pharmaceutical Drugs in 2024

Figure 22. Opthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Opthalmic Pharmaceutical Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2020-2031)

Figure 25. North America Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2020-2031)

Figure 29. Europe Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2020-2031)

Figure 30. Germany Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Opthalmic Pharmaceutical Drugs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Opthalmic Pharmaceutical Drugs Revenue Market Share by Region (2020-2031)

Figure 37. China Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2020-2031)

Figure 48. Latin America Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Opthalmic Pharmaceutical Drugs Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Opthalmic Pharmaceutical Drugs Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Opthalmic Pharmaceutical Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Opthalmic Pharmaceutical Drugs by Type (2020-2031)

Figure 58. Global Revenue Market Share of Opthalmic Pharmaceutical Drugs by Type (2020-2031)

Figure 59. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Opthalmic Pharmaceutical Drugs by Application (2020-2031)

Figure 61. Global Revenue Market Share of Opthalmic Pharmaceutical Drugs by Application (2020-2031)

Figure 62. Global Opthalmic Pharmaceutical Drugs Price (USD/Unit) by Application (2020-2031)

Figure 63. Opthalmic Pharmaceutical Drugs Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions